April 6, 2023 April 6, 2023Categories News StoriesE1411 study chair Mitchell Smith discusses the use of ibrutinib for patients with previously treated mantle cell lymphoma
March 23, 2023 March 23, 2023Categories Announcements News StoriesThe Spring 2023 advocacy blog Considering Clinical Trials is now available
March 21, 2023 March 21, 2023Categories News StoriesIn this video interview, Dr. Neha Vapiwala discusses the INDICATE (EA8191) trial and changing the trajectory of prostate cancer through radiation and imaging techniques
February 27, 2023 February 27, 2023Categories Announcements News StoriesThe TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy
February 23, 2023 February 23, 2023Categories News StoriesA focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma
February 15, 2023 February 15, 2023Categories AnnouncementsA participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger
February 10, 2023 February 10, 2023Categories AnnouncementsECOG-ACRIN announces the Remarkable Mentor to Women in Oncology Award (nominations are due March 9)
February 9, 2023 February 9, 2023Categories AnnouncementsThe application period is now open for Spring Meeting Attendance Awards for minority trainees
February 6, 2023 February 6, 2023Categories News StoriesOngoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer
